Cost-effectiveness analysis of telaprevir triple therapy for treatment-naive patients with chronic hepatitis C based on the combined efficacy data of the ADVANCE and OPTIMIZE studies
Data de publicación
2013Título da revista
Hepatology
Tipo de contido
Publicación de congreso